Regenxbio Inc at Barclays Global Healthcare Conference Transcript
Good afternoon, everyone. My name is Gena Wang. It's my great pleasure to introduce our last but not least presenting company today, REGENXBIO. With us today, we have Steve Pakola, Chief Medical Officer.
Questions & Answers
Steve, so maybe I'll start with the big picture question. So how do you plan to achieve the new strategic goal of 5x25?
Great. First, thanks, Gena, for having us. It's always great to be down in Miami and get a chance to chat and meet others. Yes, so our 5x25 plan. So this is a plan that our CEO, Ken Mills, announced last year, where we target having 5 programs, either our own or licensed programs advance to pivotal or commercial stage by 2025.
And we as a leading AAV gene therapy company, from a scientific standpoint, clinical development standpoint and also
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
